HTLV-1 and Cancer: Oncogene and OncomiR Addiction
Author Information
Author(s): Kuan-Teh Jeang
Primary Institution: National Institute of Allergy and Infectious Diseases, the National Institutes of Health
Hypothesis
Are early ATL cells addicted to the Tax oncogene while late ATL cells are addicted to oncomiRs?
Conclusion
The study suggests that early ATL cells rely on the Tax oncogene for transformation, while late ATL cells may depend on altered microRNA expression for maintaining their cancerous state.
Supporting Evidence
- HTLV-1 is the first human retrovirus linked to Adult T cell leukemia.
- Tax oncoprotein is essential for initiating transformation but not for maintaining the cancerous state.
- Late ATL cells often lack Tax expression, suggesting a shift to oncomiR addiction.
Takeaway
This study looks at how a virus can change cells into cancer cells, first needing a specific protein and later relying on tiny molecules called microRNAs to keep the cancer going.
Potential Biases
The author's views may not reflect the official stance of the National Institutes of Health.
Limitations
The study does not provide experimental data to conclusively verify the role of oncomiR inhibition as a treatment option.
Want to read the original?
Access the complete publication on the publisher's website